Seeing Is Believing
TXG is currently covered by 11 analysts with an average price target of $37.3. This is a potential upside of $9.71 (35.19%) from yesterday's end of day stock price of $27.59.
10X Genomics's activity chart (see below) currently has 35 price targets and 57 ratings on display. The stock rating distribution of TXG is 72.22% BUY, 11.11% SELL and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 50.91% with an average time for these price targets to be met of 38.18 days.
Highest price target for TXG is $65, Lowest price target is $30, average price target is $37.3.
Most recent stock forecast was given by KYLE MIKSON from CANACCORD on 28-Apr-2024.
Currently out of the existing stock ratings of TXG, 26 are a BUY (72.22%), 4 are a SELL (11.11%), 6 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
50
$22.41 (81.23%)
70
2 days ago
1/4 (25%)
$22.41 (81.23%)
119
Buy
63
$35.41 (128.34%)
68
2 months 15 days ago
2/4 (50%)
$14.55 (30.03%)
42
Buy
55
$27.41 (99.35%)
47
3 months 6 days ago
1/4 (25%)
$12.6 (29.72%)
69
Buy
4 months 18 days ago
2/2 (100%)
$4.28 (7.68%)
10
Hold
54
$26.41 (95.72%)
35
4 months 19 days ago
3/3 (100%)
$5.36 (11.02%)
19
What is TXG (10X Genomics) average time for price targets to be met?
Which analyst has the current highest performing score on TXG (10X Genomics) with a proven track record?
Which analyst has the most public recommendations on TXG (10X Genomics)?
Which analyst is the currently most bullish on TXG (10X Genomics)?
Which analyst is the currently most reserved on TXG (10X Genomics)?